(2020) 9(19):e016455
26 - Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC)
PubMed Seglen, P.O., 1976
Alpha-lipoic acid assists the bodys energy production and acts as a powerful antioxidant, helping to treat diabetic neuropathy (nerve-damage caused by the disease), protecting the liver, preventing cataracts, boosting immune function, and possibly helping to slow the progression of Alzheimers disease and increases amount of helper T-cells in the blood and helps fight many disease processes, including cancer
In other words, unlike traditional approaches, Glp-1s work alongside realistic lifestyle changes to empower the patient to establish and maintain healthier habits, resulting in sustained weight loss
Increased immunotherapy efficacy occurs through the activation of immune cells including dendritic and CD8 T cells, facilitated by the delivery of by Zn ions delivered into the TME